Click Here to View the Activity
This educational activity is intended for oncologists, radiation therapists, thoracic surgeons, pulmonologists, and other physicians in active clinical practice interested and/or involved in the management of patients with thoracic cancer.
This e-learning activity is a Webcast of the entire 12th Annual Perspectives in Thoracic Oncology meeting, which was held in New York City on November 16-17, 2007 and was chaired by Dr Corey Langer. A thorough agenda including various presentations on non-small cell lung cancer (NSCLC), small cell lung cancer, chemotherapy, prognostication utilizing molecular markers, novel targeted therapies, and various other intriguing topics comprise the meeting. Roundtable and panel discussions add interest and an interactive component to the format of this highly instructive Webcast.
After successfully completing this activity, participants should be able to:
- Describe the pathogenesis of lung cancer and concepts in prevention
- Discuss and evaluate the available methods for staging lung cancer
- Recommend the most appropriate management strategies for NSCLC, including selecting patients for therapy
- Recommend the most appropriate management strategies for small cell lung cancer
- Identify controversies in management of locally advanced NSCLC
- Translate the results of recent clinical trials in lung cancer and incorporate them into clinical practice
- Outline management strategies for esophageal cancer
- Outline management strategies for mesothelioma
- Outline management strategies for thymoma
- Describe promising new targeted and immunomodulatory agents for the treatment of thoracic malignancies
- Discuss surgical issues and controversies related to treatment of thoracic cancer
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), Imedex®, LLC must ensure balance, objectivity, independence, and scientific rigor in its educational activities. Faculty are encouraged to provide a balanced view of therapeutic options by utilizing generic names of several to ensure impartiality.
All faculty participating in an Imedex activity are required to disclose commitments to and/or relationships with pharmaceutical companies, biomedical device manufacturers or distributors, or others whose products or services may be considered to be related to the subject matter of the educational activity. Disclosure of these commitments and/or relationships is included in these course materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations.
All speakers were independently selected by the organizing committee. The following indicates the faculty disclosure declaration information and the nature of those commercial relationships.
All materials are included with the permission of the authors.
1=grant/research support 2=consultant 3=speaker’s bureau 4=stock shareholder 5=other support
| Barbara A. Burtness, MD |
Genentech BioOncology5; Array Biopharma2; Decision Resource, Inc2; Education/Outcomes3; Genmab5; Gerson Lehrman Group5; HSC3; Local Insights, Inc.2; Medscape5; MERCK & CO., Inc.5; Reed Medical Ed/Head and Neck 3rd Oncology Congress3 |
| Roger B. Cohen, MD |
Human Genome Science1 |
| Martin J. Edelman, MD |
AstraZeneca Pharmaceuticals LP1,2,3; Schering-Plough Corporation1,2,3 |
| Damian E. Dupuy, MD |
Biotex1; Endocare1; Valley Lab2,3; Veran Medical1,2 |
| Paul J. Hesketh, MD |
GlaxoSmithKline1 |
| Vera Hirsh, MD |
AstraZeneca Pharmaceuticals LP2; Roche Laboratories Inc.2 |
| Karen L. Kelly, MD |
AstraZeneca Pharmaceuticals LP2 |
| Hedy L. Kindler, MD |
OSI Pharmaceuticals2 |
| Corey J. Langer, MD |
Active Biotech1; AstraZeneca Pharmaceuticals LP1,2; Cell Therapeutics, Inc1; Celgene Corporation1; GlaxoSmithKline2; Intrabiotics Pharmaceuticals, Inc.2; Millennium Pharmaceuticals,Inc.1,2; Medimmune Inc.1; Novartis Pharmaceuticals Corporation2; Ortho Biotech Products, L.P.1,3; Pharmacia1,2; Pharmacyclics, Ltd.2; Schering-Plough Research Institute1; Vertex Pharmaceuticals Incorporated1 |
| Scott M. Lippman, MD |
OSI Pharaceuticals2 |
| Roman Perez-Soler, MD |
AstraZeneca Pharmaceuticals LP2,4; National Institutes of Health1; Novartis Pharmaceuticals Corporation2,4; Transave, Inc.2,4 |
| Charles M. Rudin, MD, PhD |
Pharmion Corporation1; MERCK & CO., Inc.2 |
| Walter Scott, MD, FACS |
Johnson & Johnson4 |
The following speakers have reported an affiliation with the supporters of this conference:
| Barbara Burtness, MD |
Amgen Inc2; Genentech BioOncology2,5; ImClone
Systems Incorporated3,5; sanofi-aventis, U.S.5 |
| Roger B. Cohen, MD |
Pfizer Inc1 |
| Corey J. Langer, MD |
Bayer HealthCare Corporation3 |
| Martin J. Edelman, MD |
Eli Lilly and Company1,2,3; Genentech BioOncology1,2,3 |
| Paul J. Hesketh, MD |
sanofi-aventis, U.S.1 |
| Karen L. Kelly, MD |
Amgen Inc2; Bristol-Myers Squibb Company2; Genentech BioOncology2; ImClone Systems Incorporated2 |
| Hedy L. Kindler, MD |
Eli Lilly and Company1; Genentech BioOncology1 |
| Corey J. Langer, MD |
Amgen Inc1,2; Bristol-Myers Squibb Company1,2,3; Eli Lilly and Company1,3; Genentech BioOncology1,2,3; ImClone Systems Incorporated2; Pfizer Inc1; sanofi-aventis, U.S.1,2,3 |
| Roman Perez-Soler, MD |
Amgen Inc2,4; Eli Lilly and Company2,3,4; Genetech BioOncology2,3,4 |
| Charles M. Rudin, MD, PhD |
Genentech BioOncology2 |
The following speakers do not report any affiliation:
George R. Blumenschein, Jr, MD
Walter J. Curran, Jr, MD
Carolyn M. Dresler, MD, MPA
Tracey Evans, MD
Larry R. Kaiser, MD
John C. Kucharczuk, MD
York E. Miller, MD
Nevin Murray, MD, FRCPC
Harvey I. Pass, MD
Michael C. Perry, MD
Helen J. Ross, MD
Eric Vallieres, MD, FRCSC
Imedex, LLC Staff Disclosure of Financial Relationships
Imedex, LLC is a subsidiary of AmerisourceBergen Specialty Group, which is a subsidiary of AmerisourceBergen Company. All Imedex staff members, except for the following, who are in a position to control the content of this activity, have no financial relationships with any commercial interests that are relevant to this activity:
Keith Steward, MD, MBA, owns shares of Pfizer Inc and Johnson & Johnson, as well as stock options for AmerisourceBergen.
Chris Bolwell owns shares of GlaxoSmithKline and stock options for AmerisourceBergen.
Kenneth Richardson, MD, Bradley Bongiovanni, ND, and Becky Lynch, RN, own stock options for AmerisourceBergen.
This activity is sponsored by Imedex, LLC.
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity for a maximum of 12.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
In order to receive credit, participants must successfully complete the post-test and complete the online evaluation form. You will receive an online CME statement of credit to print for your records.
For questions regarding the accreditation of this activity, please contact
Imedex
4325 Alexander Drive
Alpharetta, GA 30022
Fax: +1(770) 751-7334
Email: enduring@imedex.com
This Webcast may contain information about experimental and other uses of drugs or devices that are not currently approved by the US Food and Drug Administration (FDA) and/or other national regulatory agencies in the United States and other countries. Participants in the United States are encouraged to consult the FDA-approved product labeling for any drug or device mentioned in this program before use. Participants from other countries should consult with their respective regulatory authorities.
The opinions expressed in this Webcast are the opinions of the authors and do not necessarily reflect the opinions of Imedex or the American School of Oncology.
The following companies have provided unrestricted educational grants in support of this activity: Pfizer Inc; Amgen Inc; Genentech BioOncology; sanofi-aventis, U.S.; Eli Lilly and Company; Bristol-Myers Squibb Company; Bayer HealthCare Corporation/Onyx Pharmaceuticals Inc; Fujirebio Diagnostics.
Click Here to View the Activity |
